Cardlytics shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 revenue guidance below estimates.
Portfolio Pulse from Benzinga Newsdesk
Cardlytics shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 revenue guidance below estimates.
August 08, 2024 | 5:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cardlytics shares are trading lower due to disappointing Q2 financial results and lower-than-expected Q3 revenue guidance.
The company's worse-than-expected Q2 financial results and lower Q3 revenue guidance are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100